scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF00562320 |
P953 | full work available at URL | http://link.springer.com/article/10.1007/BF00562320/fulltext.html |
http://link.springer.com/content/pdf/10.1007/BF00562320 | ||
http://link.springer.com/content/pdf/10.1007/BF00562320.pdf | ||
P698 | PubMed publication ID | 1233247 |
P2093 | author name string | M. Ehrnebo | |
I. Odar-Cederlöf | |||
P2860 | cites work | Immunochemical quantitation of antigens by single radial immunodiffusion | Q28248574 |
Impairment of cognitive function associated with hydroxyamylobarbitone accumulation in patients with renal insufficiency | Q35174545 | ||
Anemia in uremia. Hemolysis evaluated by common methods and application of the bilirubin turnover method | Q45139788 | ||
Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding | Q47840215 | ||
The effect of bovine and human serum albumins on the mechanical properties of human erythrocyte membranes | Q47965872 | ||
Determination of serum creatinine by a direct colorimetric method | Q48010258 | ||
Effects of psychotropic drugs on the erythrocyte permeability to glucose and ethylidene glucose | Q52733953 | ||
All lipid-soluble anaesthetics protect red cells. | Q52737853 | ||
Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. | Q53755058 | ||
The binding of indomethacin, salicylate and phenobarbitone to human whole blood in vitro. | Q54586946 | ||
Complex formation between macromolecules and drugs. IX. The competition between two sulfa drugs and phenobarbital, pentobarbital or phenoxymethyl penicillin for binding sites on human serum albumin | Q67273356 | ||
Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution | Q68749158 | ||
Pentazocine binding to blood cells and plasma proteins | Q68794088 | ||
Effect of protein binding on the distribution of 5,5-diphenylhydantoin between plasma and red cells | Q69035464 | ||
The binding of phenothiazines to oxyhemoglobin A and S | Q70035578 | ||
The Alteration of Plasma Proteins in Uremia as Reflected in their Ability to Bind Digitoxin and Diphenylhydantoin | Q70440093 | ||
Age differences in drug binding by plasma proteins: Studies on human foetuses, neonates and adults | Q70681355 | ||
Interindividual Differences in the Protein Binding of Sulfonamides: The Effect of Disease and Drugs 1,2 | Q71153617 | ||
The membrane concentraton of a local anesthetic (Chlorpromazine) | Q72535769 | ||
THE IMPORTANCE OF BINDING TO ALBUMIN, BODY CELLS AND BACTERIA FOR PHARMACODYNAMICS AND EFFECT OF MEDICINAL SUBSTANCES | Q76882624 | ||
RAPID PASSAGE OF ORGANIC ANIONS INTO HUMAN RED CELLS | Q76943789 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacology | Q128406 |
phenytoin | Q410400 | ||
P304 | page(s) | 445-453 | |
P577 | publication date | 1975-08-01 | |
1975-08-14 | |||
P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
P1476 | title | Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients | |
P478 | volume | 8 |
Q72525469 | A Toxicological Evaluation of Different Adsorbents in Hemoperfusion |
Q39631572 | A modified Sperber technique for direct estimation of true renal tubular excretion fraction |
Q71295379 | Alteration of drug-protein binding in renal disease |
Q40142216 | Anticonvulsant drugs. An update |
Q39621414 | Binding of Drugs by Albumin Plasma Protein |
Q39665699 | Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure |
Q28543246 | Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy |
Q26746873 | Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status Epilepticus |
Q39281328 | Cyclobarbital as a test substance for oxidative drug metabolism in man. Findings in neuropsychiatric patients |
Q37950599 | Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II). |
Q67541157 | Distribution of pentobarbital and diphenylhydantoin between plasma and cells in blood: effect of salicylic acid, temperature and total drug concentration |
Q34518414 | Diurnal variations in plasma diazepam concentrations associated with reciprocal changes in free fraction |
Q70426620 | Drug distribution in whole blood of mothers and their newborn infants: studies of cloxacillin and flucloxacillin |
Q39754383 | Free drug concentration monitoring in clinical practice. Rationale and current status |
Q52618581 | Gentamicin and phenytoin sieving through hollow-fiber polysulfone hemofilters. |
Q40148602 | Impaired Binding of Drugs and Endogenous Ligands in Renal Diseases |
Q34621171 | Pethidine binding in whole blood: methodology and clinical significance |
Q70540684 | Pethidine binding to blood cells and plasma proteins in old and young subjects |
Q39228974 | Pharmaco-kinetic aspects of protein-binding (author's transl) |
Q70087537 | Pharmacokinetics and distribution of flucloxacillin in pacemaker patients |
Q69128799 | Pharmacokinetics of free and total flucloxacillin in newborn infants |
Q70416631 | Pharmacokinetics of free and total sodium valproate in adolescents and young adults during maintenance therapy |
Q40771925 | Plasma Protein Binding of Phenytoin and Warfarin in Patients Undergoing Renal Transplantation1 |
Q39851158 | Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats |
Q53785712 | Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency. |
Q39467922 | Salivary phenytoin concentrations in epilepsy and in chronic renal failure |
Q71295407 | The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin |
Q40640466 | The binding of drugs to plasma proteins from patients with poor renal function |
Q67053866 | The clinical pharmacokinetics of phenytoin |
Q41947254 | Variations in drug free fraction during alcohol withdrawal |